Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Puma Biotechnology (PBYI) Return on Invested Capital (2021 - 2025)

Puma Biotechnology's Return on Invested Capital history spans 5 years, with the latest figure at 0.23% for Q3 2025.

  • For Q3 2025, Return on Invested Capital fell 6.0% year-over-year to 0.23%; the TTM value through Sep 2025 reached 0.23%, down 6.0%, while the annual FY2024 figure was 0.27%, 30.0% down from the prior year.
  • Return on Invested Capital reached 0.23% in Q3 2025 per PBYI's latest filing, down from 0.33% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 1.19% in Q1 2023 to a low of 11.5% in Q1 2022.
  • Average Return on Invested Capital over 5 years is 0.31%, with a median of 0.26% recorded in 2025.
  • Peak YoY movement for Return on Invested Capital: soared 1269bps in 2023, then tumbled -92bps in 2024.
  • A 5-year view of Return on Invested Capital shows it stood at 0.9% in 2021, then plummeted by -32bps to 0.61% in 2022, then tumbled by -31bps to 0.42% in 2023, then tumbled by -42bps to 0.24% in 2024, then dropped by -5bps to 0.23% in 2025.
  • Per Business Quant, the three most recent readings for PBYI's Return on Invested Capital are 0.23% (Q3 2025), 0.33% (Q2 2025), and 0.26% (Q1 2025).